Similar articles

• Stilboestrol and adenocarcinoma of the vagina. Statement by the Australian Drug Evaluation Committee.

  [No authors listed] [No authors listed] Med J Aust. 1972 Sep 9;2(11):622-3. Med J Aust. 1972. PMID: 5082789 No abstract available.
• [Vaginal adenocarcinoma as a late result of treatment of threatened abortion with diethylstilbestrol].

  Presl J. Presl J. Cesk Gynekol. 1973 Jul;38(6):473-4. Cesk Gynekol. 1973. PMID: 4731614 Czech. No abstract available.
• Stilbestrol and vaginal cancer.

  Benton BD. Benton BD. Am J Nurs. 1974 May;74(5):900-1. Am J Nurs. 1974. PMID: 4493696 No abstract available.
• Epidemiology of vaginal adenocarcinoma and adenosis: current status.

  Weiss K. Weiss K. J Am Med Womens Assoc (1972). 1975 Feb;30(2):59-63. J Am Med Womens Assoc (1972). 1975. PMID: 163267 Review. No abstract available.
• [Transplacental cancerogenic effect of stilbestrol].

  Drobnjak B. Drobnjak B. Lijec Vjesn. 1973 Jul;95(7):408-10. Lijec Vjesn. 1973. PMID: 4590502 Review. Croatian. No abstract available.